The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
1 Year | 5 Year | 5 Year Annualized | Since IPO | |
---|---|---|---|---|
ACHC | -54.59% | -24.78% | -5.54% | +161% |
S&P | +14.5% | +93.32% | +14.09% | +450% |
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment is classified in the following categories: acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, and outpatient community-based services. The U.K. Facilities segment provides inpatient services through facilities, including mental health hospitals, clinics, care homes, schools, colleges, and children's homes. The company was founded in January 2005 and is headquartered in Franklin, TN.
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
The company's latest quarterly update impressed investors.
Q2 2025 | YOY Change | |
---|---|---|
Revenue | $869.23M | 9.2% |
Gross Profit | $192.26M | 0.8% |
Gross Margin | 22.12% | -1.8% |
Market Cap | $2.09B | -66.6% |
Market Cap / Employee | $0.08M | 0.0% |
Employees | 25.5K | 8.5% |
Net Income | $37.94M | -53.1% |
EBITDA | $191.30M | 7.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
Q2 2025 | YOY Change | |
---|---|---|
Net Cash | $131.42M | 70.3% |
Accounts Receivable | $408.54M | 4.9% |
Inventory | 5.8 | -2.9% |
Q2 2025 | YOY Change | |
---|---|---|
Long Term Debt | $2.34B | 24.6% |
Short Term Debt | $43.99M | -53.5% |
Q2 2025 | YOY Change | |
---|---|---|
Return On Assets | 2.32% | 2.4% |
Return On Invested Capital | 3.73% | 0.8% |
Q2 2025 | YOY Change | |
---|---|---|
Free Cash Flow | -$34.24M | -302.5% |
Operating Free Cash Flow | $133.50M | -22.0% |
Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
---|---|---|---|---|---|
Price to Earnings | 20.79 | 14.28 | 14.88 | 14.95 | - |
Price to Book | 1.92 | 1.20 | 0.91 | 0.67 | -68.75% |
Price to Sales | 1.87 | 1.16 | 0.88 | 0.64 | -68.75% |
Price to Tangible Book Value | 8.39 | 5.25 | 3.77 | 2.99 | -74.31% |
Price to Free Cash Flow TTM | 186.98 | - | |||
Enterprise Value to EBITDA | 42.68 | 40.45 | 41.10 | 23.27 | -49.42% |
Free Cash Flow Yield | 0.5% | - | |||
Return on Equity | 9.8% | 8.7% | 6.4% | 4.6% | -2750.97% |
Total Debt | $2.01B | $2.10B | $2.33B | $2.39B | 20.87% |
ACHC earnings call for the period ending September 30, 2021.
ACHC earnings call for the period ending June 30, 2021.
ACHC earnings call for the period ending March 31, 2021.
ACHC earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.